Your browser doesn't support javascript.
loading
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).
Pergola, Pablo E; Davidson, Michael; Jensen, Camilla; Mohseni Zonoozi, Amir A; Raj, Dominic S; Andreas Schytz, Philip; Tuttle, Katherine R; Perkovic, Vlado.
Afiliación
  • Pergola PE; Renal Associates P.A., San Antonio, Texas.
  • Davidson M; Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Jensen C; Novo Nordisk A/S, Søborg, Denmark.
  • Mohseni Zonoozi AA; Novo Nordisk A/S, Søborg, Denmark.
  • Raj DS; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC.
  • Andreas Schytz P; Novo Nordisk A/S, Søborg, Denmark.
  • Tuttle KR; School of Medicine, University of Washington, and Providence Health Care, Spokane, Washington.
  • Perkovic V; University of New South Wales Sydney, Sydney, Australia.
J Am Soc Nephrol ; 35(1): 74-84, 2024 01 01.
Article en En | MEDLINE | ID: mdl-38088558

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Anemia / Fallo Renal Crónico Límite: Adult / Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Anemia / Fallo Renal Crónico Límite: Adult / Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2024 Tipo del documento: Article